Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden

Authors:

Abstract
No abstract available
Funding Information
  • Sigrid Juséliuksen Säätiö
  • Swedish Foundation for Strategic Research (IRC15-0067)
  • Swedish Research Council (2017-02688)
  • Swedish Research Council (2020-02191)
  • European Commission Seventh Framework Programme for Research and Technological Development Health (269045)
  • Sweden's Innovation Agency (2023-04234)
  • AstraZeneca (521-2010-3490)
  • AstraZeneca (2014-6395)
  • AstraZeneca (349-2006-237)
  • AstraZeneca (2009-1039)
  • AstraZeneca (2012-5538)
  • AstraZeneca (2010-5983)
  • AstraZeneca (2015-2558)
  • Lund University Medical Faculty Foundation
  • Folkhälsan Research Center
  • Director Albert Pahlsson Foundation for Research and Charity
  • Seventh Framework Programme
  • AstraZeneca R&D Gothenburg
  • Swedish Diabetes Association Research Foundation
  • Research Council of Finland (263401)
  • Research Council of Finland (267882)
  • Bo and Kerstin Hjelt Diabetes Foundation
  • Heart and Lung Foundation (20220606)
  • Heart and Lung Foundation (20180640)
  • Diabetesförbundet
  • Crafoord Foundation
  • European Research Council
  • Diabetes Wellness Foundation Network Sweden (25-420 PG)
  • Novo Nordisk Foundation (NNF18OC0034408)
  • Novo Nordisk Foundation (NNF21OC0070457)

This publication has 26 references indexed in Scilit: